NLRP3 and myeloid sarcoma: First, we only showed that ghrelin inhibited the NLRP3 inflammasome signaling pathway, and therefore, we are not sure whether these neuroprotective effects involved other inflammasomes which have been reported to participate in the pathogenesis of MS (Freeman et al., 2017; Vidmar et al., 2019).